COST-EFFECTIVENESS OF DENOSUMAB IN PREVENTING OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN FROM THE PRIVATE HEALTH CARE SETTING PERSPECTIVE IN BRAZIL

被引：1
|
作者：
Barbosa, E. G. [1 ]
Machado, M. [1 ]
Araujo, G. T. B. D. [2 ]
Etto, H. [2 ]
Fonseca, M. [3 ]
Olimpio, A. [1 ]
机构：
[1] GlaxoSmithKline Ltda, Rio De Janeiro, Brazil
[2] Axia Bio, Sao Paulo, Brazil
[3] Fed Univ Sao Paulo Axia Bio Consulting, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1396
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A446 / A447
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan
    Mori, Takahiro
    Crandall, Carolyn J.
    Fujii, Tomoko
    Ganz, David A.
    ARCHIVES OF OSTEOPOROSIS, 2021, 16 (01)
  • [42] Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil
    Cazarim, Maurilio de Souza
    Leira Pereira, Leonardo Regis
    PLOS ONE, 2018, 13 (03):
  • [43] DENOSUMAB REDUCED OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS WITH PRIOR FRACTURE: RESULTS FROM FREEDOM
    Palacios, Santiago
    Rizzoli, R.
    Zapalowski, C.
    Resch, H.
    Adami, S.
    Adachi, J. D.
    Gallagher, J. C.
    Feldman, R. G.
    Kendler, D. L.
    El-Haschimi, K.
    Wang, A.
    Wagman, R. B.
    Boonen, S.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S299 - S300
  • [44] Cost-Effectiveness of Zoledronic Acid Versus Oral Alendronate for Postmenopausal Osteoporotic Women in China
    You, Ruxu
    Zhang, Yu
    Wu, David Bin-Chia
    Liu, Jinyu
    Qian, Xinyu
    Luo, Nan
    Moris, Takahiro
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [45] COST-EFFECTIVENESS ANALYSIS OF ETONOGESTREL IMPLANT VERSUS LEVONORGESTREL INTRAUTERINE SYSTEM FROM THE PRIVATE HEALTH SECTOR PERSPECTIVE IN BRAZIL
    Coutinho, M. B.
    Haas, L. C.
    Carvalho, L. C.
    Risso, F.
    VALUE IN HEALTH, 2017, 20 (05) : A286 - A286
  • [46] The cost-effectiveness of calcium and vitamin D or hormone replacement therapy in the prevention of osteoporosis and osteoporotic fractures in Canadian postmenopausal women.
    Papadimitropoulos, EA
    Goeree, R
    Blackhouse, G
    Coyte, P
    Josse, RG
    Adachi, J
    Greenwood, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S384 - S384
  • [47] Modelled cost-effectiveness and cost-utility analysis of various treatment strategies in polish osteoporotic postmenopausal women without previous vertebral fractures
    Orlewska, E
    Lis, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S46 - S46
  • [48] The impact of cost-effectiveness on public and private policies in health care: An international perspective - Conclusions and implications
    Sloan, FA
    Grabowski, HG
    SOCIAL SCIENCE & MEDICINE, 1997, 45 (04) : 645 - 647
  • [49] The impact of cost-effectiveness on public and private policies in health care: An international perspective - Introduction and overview
    Sloan, FA
    Grabowski, HG
    SOCIAL SCIENCE & MEDICINE, 1997, 45 (04) : 505 - 510
  • [50] COST-EFFECTIVENESS ANALYSIS OF ENHANCING ADHERENCE TO BISPHOSPHONATES THERAPY IN THE SETTING OF PRIMARY PREVENTION OF OSTEOPOROTIC FRACTURES
    Scotti, L.
    Zambon, A.
    Arfe, A.
    Ghirardi, A.
    Nicotra, F.
    Baio, G.
    Corrao, G.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S743 - S743
12345